These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15490387)

  • 1. Meningovascular syphilis and improvement with tissue-plasminogen activator (T-PA).
    Han JH; Lee CC; Crupi RS
    Am J Emerg Med; 2004 Sep; 22(5):426-7. PubMed ID: 15490387
    [No Abstract]   [Full Text] [Related]  

  • 2. Should a hospital without a neurologist use t-PA to treat stroke?
    Krieger DW
    Cleve Clin J Med; 1999; 66(10):585-6. PubMed ID: 10598361
    [No Abstract]   [Full Text] [Related]  

  • 3. Tissue-type plasminogen activator (t-PA) and single chain urokinase-type plasminogen activator (scu-PA): potential for fibrin-specific thrombolytic therapy.
    Collen D
    Prog Hemost Thromb; 1986; 8():1-18. PubMed ID: 3104986
    [No Abstract]   [Full Text] [Related]  

  • 4. Serine-proteases as plasminogen activators in terms of fibrinolysis.
    Flemmig M; Melzig MF
    J Pharm Pharmacol; 2012 Aug; 64(8):1025-39. PubMed ID: 22775207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Structure, function and use of fibrinolysis-promoting and inhibiting factors].
    Bachmann F
    Arzneimittelforschung; 1988 Mar; 38(3A):474-8. PubMed ID: 3134901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reteplase but not alteplase affects early soluble PECAM-1 and P-selectin release in patients with acute myocardial infarction.
    Gurbel PA; Dalesandro MR; Serebruany VL
    Thromb Haemost; 1998 Oct; 80(4):725. PubMed ID: 9799011
    [No Abstract]   [Full Text] [Related]  

  • 7. Overview: hyperacute rt-PA stroke treatment. The NINDS rt-PA Stroke Study Group.
    Donnarumma R; Kongable G; Barch C; Braimah J; Bratina P; Daley S; Rapp K; Sailor S; Spilker J
    J Neurosci Nurs; 1997 Dec; 29(6):351-5. PubMed ID: 9479655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergism of tissue-type plasminogen activator (t-PA) and single-chain urokinase-type plasminogen activator (scu-PA) on clot lysis in vitro and a mechanism for this effect.
    Gurewich V; Pannell R
    Thromb Haemost; 1987 Jun; 57(3):372-3. PubMed ID: 3116707
    [No Abstract]   [Full Text] [Related]  

  • 9. Molecular mechanisms of thrombolysis: implications for therapy.
    Collen D; Lijnen HR
    Biochem Pharmacol; 1990 Jul; 40(2):177-86. PubMed ID: 2115776
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular mechanism of action of newer thrombolytic agents.
    Collen D
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):11B-15B. PubMed ID: 3117858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tabetic arthropathy revealing neurosyphilis: a new observation.
    Lakjiri S; Mernissi FZ
    Pan Afr Med J; 2014; 18():198. PubMed ID: 25419325
    [No Abstract]   [Full Text] [Related]  

  • 12. The search for the ideal thrombolytic agent.
    Verstraete M
    J Am Coll Cardiol; 1987 Nov; 10(5 Suppl B):4B-10B. PubMed ID: 2959714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tabes dorsalis of sudden onset associated with possible transverse myelitis.
    Wigfield AS
    Br J Vener Dis; 1970 Jun; 46(3):262-3. PubMed ID: 5430348
    [No Abstract]   [Full Text] [Related]  

  • 14. [Ataxia revealing a spinal tabetic arthropathy].
    Hsaini Y; Karouache A; Satte A; Zerhouni A; Bourazza A
    Presse Med; 2010 Oct; 39(10):1109-11. PubMed ID: 20466508
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacology of thrombolytic drugs.
    Verstraete M; Collen D
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):33B-40B. PubMed ID: 3097100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Validity of the GUSTO trial's main conclusion. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronaries.
    Eisenberg C
    Pharmacotherapy; 1997; 17(4):850-2. PubMed ID: 9250573
    [No Abstract]   [Full Text] [Related]  

  • 17. [New thrombolytic agents].
    Okada K
    Rinsho Byori; 1992 Mar; Suppl 92():115-30. PubMed ID: 1583770
    [No Abstract]   [Full Text] [Related]  

  • 18. Tabes dorsalis progressing to general paresis after 20 years despite routine penicillin therapy.
    Giles AJ
    Br J Vener Dis; 1980 Dec; 56(6):368-71. PubMed ID: 7448579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New thrombolytic agents in myocardial infarction].
    Charbonnier B; Lang M; Brochier M
    Arch Mal Coeur Vaiss; 1987 Nov; 80(12):1785-91. PubMed ID: 3128222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant tissue-type plasminogen activator therapy of thrombosis in 16 neonates.
    Farnoux C; Camard O; Pinquier D; Hurtaud-Roux MF; Sebag G; Schlegel N; Beaufils F
    J Pediatr; 1998 Jul; 133(1):137-40. PubMed ID: 9672527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.